Difficulty: Medium
Average Score: 70%
Practice
A 62-year-old woman with symptoms of feeling blue, sad, and without feelings presents to her primary care physician for treatment. She has a prior medical history of narrow-angle glaucoma. Which of the following treatments should be avoided in this patient?
Correct answer
A
Rationale
In this scenario, the correct answer is option A) Amitriptyline, which should be avoided in a patient with narrow-angle glaucoma. Amitriptyline is a tricyclic antidepressant that can cause pupillary dilation and precipitate acute angle-closure glaucoma in patients predisposed to this condition. This medication can increase intraocular pressure, which is contraindicated in individuals with narrow-angle glaucoma due to the risk of exacerbating this condition and causing serious complications.
Option B) Bupropion is a reasonable choice in this case as it is not known to affect intraocular pressure and is not contraindicated in patients with narrow-angle glaucoma.
Option C) Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) which is generally safe for use in patients with narrow-angle glaucoma and can be considered as a treatment option.
Option D) Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA) that does not significantly impact intraocular pressure and can be used in patients with narrow-angle glaucoma without major concerns.
Educationally, this question highlights the importance of considering comorbidities and contraindications when prescribing medications, especially in vulnerable patient populations. Understanding the potential side effects and interactions of CNS drugs is crucial for safe and effective pharmacological management.
Option B) Bupropion is a reasonable choice in this case as it is not known to affect intraocular pressure and is not contraindicated in patients with narrow-angle glaucoma.
Option C) Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) which is generally safe for use in patients with narrow-angle glaucoma and can be considered as a treatment option.
Option D) Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA) that does not significantly impact intraocular pressure and can be used in patients with narrow-angle glaucoma without major concerns.
Educationally, this question highlights the importance of considering comorbidities and contraindications when prescribing medications, especially in vulnerable patient populations. Understanding the potential side effects and interactions of CNS drugs is crucial for safe and effective pharmacological management.